Epsilon M&A Deal Report - ARTeSYN Biosolutions Ireland
Transaction Multiples for the Valuation of Private Companies
Repligen / ARTeSYN Biosolutions Ireland
No EMAT :
103381
Announced Date :
27/10/2020
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Repligen
Target :
ARTeSYN Biosolutions Ireland
Country :
Ireland
Sector of activity :
- Medical Equipment > Health Care Providers, Medical Equipment and Supplies > Health, Pharmaceuticals & Biotechnology > Diagnostic Medical Equipment
Business Description :
Founded in 2015, ARTeSYN Biosolutions is a manufacturer of innovative single-use solutions for the downstream bioprocessing industry. > Suite of single-use solutions have been created with the goal...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
ns | ||||||
| Current |
|
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Diagnostic Medical Equipment » = 37
| Date | Acquirer | Target | Country | Multiples | See details |
| 02/10/2020 | Sartorius | BIA Separations | Slovenia | * | 103347 |
| 29/06/2017 | DomusVi (DVD Participations) | Clos Saint Jean (Résidence Port Royal) | Nord | ** | 103042 |
Source: Epsilon Research / EMAT
